McKesson Corporation (MCK)
McKesson Corporation (MCK) is a healthcare services and information technology company that distributes pharmaceuticals, medical supplies, and healthcare technology solutions. Founded in 1833, it has grown to become one of the largest healthcare distribution companies in North America, providing essential services to pharmacies, hospitals, and healthcare providers worldwide.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| October 1, 2025 | $0.82 | 2025-09-02 | 2025-09-02 |
| July 1, 2025 | $0.71 | 2025-06-02 | 2025-06-02 |
| April 1, 2025 | $0.71 | 2025-03-03 | 2025-03-03 |
| January 2, 2025 | $0.71 | 2024-12-02 | 2024-12-02 |
| October 1, 2024 | $0.71 | 2024-08-30 | 2024-09-02 |
Dividends Summary
- McKesson Corporation has issued 87 dividend payments over the past 21 years
- The most recent dividend was paid 21 days ago, on October 1, 2025
- The highest dividend payed out to investors during this period was $0.82 per share
- The average dividend paid during this period was $0.29 per share.
Company News
The global healthcare supply chain management market is projected to grow from $3.60 billion in 2025 to $9.20 billion by 2034, with a CAGR of 11.05%. North America leads the market, driven by technological advancements, AI integration, and demand for efficient healthcare logistics.
The Practice Management Systems market is expected to grow to $36.33 billion by 2031, with a 9.3% CAGR, driven by digital healthcare solutions, operational efficiency needs, and increasing telemedicine adoption.
Five stocks are delivering strong total returns in 2025 by increasing their dividends by 10% or more, demonstrating commitment to shareholder value through consistent dividend growth and impressive stock performance.
McKesson reported strong Q4 FY2025 results, with 19% revenue growth and 15% adjusted net profit growth. However, the company missed analyst estimates on both revenue and adjusted earnings per share. McKesson also announced plans to spin off its medical-surgical solutions unit into a new, independent company.
DexCom, Inc. is scheduled to release its second-quarter 2024 results on July 25. The company's revenues are expected to grow 19% year-over-year, driven by increased product volume and global awareness of its continuous glucose monitoring system. However, rising costs and competition may have weighed on its performance.
